LEADER 02851nam 22006013u 450 001 996339089303316 005 20230721021218.0 010 $a1-282-09392-4 010 $a9786612093920 010 $a1-84692-610-6 035 $a(CKB)1000000000747783 035 $a(EBL)434064 035 $a(OCoLC)666932718 035 $a(SSID)ssj0000383582 035 $a(PQKBManifestationID)12110796 035 $a(PQKBTitleCode)TC0000383582 035 $a(PQKBWorkID)10331848 035 $a(PQKB)10553549 035 $a(Au-PeEL)EBL434064 035 $a(MiAaPQ)54807 035 $a(EXLCZ)991000000000747783 100 $a20130418d2009|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTherapeutic Strategies in Pulmonary Arterial Hypertension$b[electronic resource] 205 $a1st ed. 210 $aOxford $cAtlas Medical Publishing Ltd$d2009 215 $a1 online resource (101 p.) 225 1 $aTherapeutic Strategies 300 $aDescription based upon print version of record. 311 $a1-84692-053-1 327 $aContents; Editors and Contributors; Chapter 1: Imaging of the right heart and pulmonary circulation; Chapter 2: Exercise testing and haemodynamics; Chapter 3: Epidemiology of pulmonary arterial hypertension; Chapter 4: Current treatment of PAH: prostanoids, phosphodiesterase-5 inhibitors and stimulators of soluble guanylate cyclase; Chapter 5: The future treatment of pulmonary hypertension; Chapter 6: Endothelin receptor antagonists; Chapter 7: Gene and stem cell therapy in pulmonary arterial hypertension; Abbreviations; Index 330 $aPulmonary arterial hypertension (PAH) is a rare condition; yet this very rarity can be a disadvantage when it comes to treatment, making PAH difficult to diagnose, and resulting in suboptimal patient care. Furthermore, the global burden of PAH remains poorly understood and largely underestimated, as PAH commonly presents as a comorbidity with such conditions as systemic sclerosis, COPD, idiopathic pulmonary fibrosis and left-heart dysfunction. However, in recent years there has been significant investment in developing new therapies for PAH, and treatment for this previously neglected disease 410 0$aTherapeutic Strategies 606 $aHypertension, Pulmonary 606 $aPulmonary artery 606 $aPulmonary hypertension 615 4$aHypertension, Pulmonary. 615 4$aPulmonary artery. 615 4$aPulmonary hypertension. 676 $a616.24 700 $aPeacock$b A$01001220 701 $aBarbera?$b J$01001221 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339089303316 996 $aTherapeutic Strategies in Pulmonary Arterial Hypertension$92298043 997 $aUNISA